PharmaVoice ٩ مارس ٢٠٢٦ The first KRAS drugs have been sluggish on the market. Will the next generation fare better?
PharmaVoice ٣ مارس ٢٠٢٦ J&J’s blockbuster Spravato is setting the stage for managing psychedelics’ risks
PharmaVoice ١٩ فبراير ٢٠٢٦ Will vaccine regulatory uncertainty chill innovation? Pharma execs sound off.